Q1 2026 CV Sciences Inc Earnings Call Transcript

May 14, 2026 / 08:30 PM GMT
Release Date Price: $0.0395

Key Points

Positve
  • CV Sciences Inc (CVSI) maintained a strong gross margin of 48.9% despite a challenging economic environment.
  • Operating expenses were reduced by 13.3% compared to the first quarter of 2025, reflecting a focus on cost discipline.
  • The company achieved an adjusted EBITDA loss improvement to $0.1 million from $0.3 million in the prior year.
  • CV Sciences Inc (CVSI) remains the number one selling hemp extract brand in the natural product retail sales channel.
  • The launch of the Plus Health Empower product, a non-cannabinoid supplement, has received encouraging feedback from consumers and retailers.
Negative
  • Revenue for the quarter was $3.2 million, down 3% sequentially and 11% year-over-year, driven by a 12% decline in unit sales.
  • The CBD market remains fragmented and highly competitive, posing ongoing challenges for CV Sciences Inc (CVSI).
  • The regulatory environment continues to be complicated, with inconsistent federal guidance creating challenges and increased costs.
  • Net loss for the quarter was $0.6 million compared to $0.1 million in the prior-year period.
  • The company is facing revenue pressure from regulatory challenges, which may require modifications to its product offerings.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CVSI.PK - CV Sciences Inc
Q1 2026 CV Sciences Inc Earnings Call
May 14, 2026 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon, ladies and gentlemen, and welcome to the CV Sciences Q1 2026 Earnings Call.

All participants will be in a listen-only mode. There will be an opportunity to ask questions later during the conference.

If you should need assistance during the call, please signal an operator by pressing star, then zero.

Please note that this event is being recorded.

I will now like to hand the conference over to Brendan Hawkins, Investor Relations. Please go ahead, sir.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, and good afternoon, everyone.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot